We are live on ! Find out more
BLU

BELLUS Health Inc.
BLU

Delisted

BLU was delisted on the 28th of June, 2023.

Back to rankings

39 hedge funds and large institutions have $216M invested in BELLUS Health Inc. in 2019 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 6

33% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 9

27% more capital invested

Capital invested by funds: $170M → $216M (+$46M)

3% less funds holding

Funds holding: 40 → 39 (-1)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
39
Holders Change
-1
Holders Change %
-2.5%
% of All Funds
0.77%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
10
Increased
12
Reduced
9
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PC
Polar Capital
United Kingdom
+$6.22M
2
RI
RTW Investments
New York
+$4.53M
3
SB
Samsara BioCapital
California
+$3.34M
4
MP
Mangrove Partners
Connecticut
+$836K
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$677K

Top Sellers

Rank Fund Capital Flow
1
First Manhattan
First Manhattan
New York
-$2.91M
2
Citadel Advisors
Citadel Advisors
Florida
-$2.18M
3
Artisan Partners
Artisan Partners
Wisconsin
-$1.12M
4
Goldman Sachs
Goldman Sachs
New York
-$683K
5
Morgan Stanley
Morgan Stanley
New York
-$377K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
$131K +$118K +17,275 New
OAM
27
Oxford Asset Management
United Kingdom
$120K +$108K +15,781 New
Bank of Montreal
28
Bank of Montreal
Ontario, Canada
$101K +$90.6K +13,255 New
BFM
29
Boothbay Fund Management
New York
$92K -$1.96K -287 -2%
Deutsche Bank
30
Deutsche Bank
Germany
$65K +$58.3K +8,529 +8,529%
Royal Bank of Canada
31
Royal Bank of Canada
Ontario, Canada
$24K -$21.2K -3,099 -49%
ClearBridge Investments
32
ClearBridge Investments
New York
$21K – – –
Morgan Stanley
33
Morgan Stanley
New York
$18K -$377K -55,089 -96%
UBS Group
34
UBS Group
Switzerland
$8K -$6.72K -983 -50%
PCM
35
Prelude Capital Management
New York
$4K +$212 +31 +7%
GCM
36
Gables Capital Management
Florida
$1K – – –
Toronto Dominion Bank
37
Toronto Dominion Bank
Ontario, Canada
$1K +$684 +100 +256%
LC
38
Lindbrook Capital
California
$1K +$1.07K +156 New
Artisan Partners
39
Artisan Partners
Wisconsin
– -$1.12M -175,000 Closed
Goldman Sachs
40
Goldman Sachs
New York
– -$683K -106,924 Closed
Point72 Asset Management
41
Point72 Asset Management
Connecticut
– -$257K -40,294 Closed
MIM
42
Monashee Investment Management
Massachusetts
– -$192K -30,000 Closed
Bank of America
43
Bank of America
North Carolina
– -$114K -17,772 Closed
CSS
44
Cubist Systematic Strategies
Connecticut
– -$24K -3,787 Closed
1
2

BLU Hedge Fund Activity: Q4 2019 in Review

39 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in BELLUS Health Inc. (BLU) for Q4 2019, worth a combined $216M — up 27% from $170M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new BLU positions and 6 closed out — a net gain of 4 holders — while 12 added to existing stakes and 9 trimmed.

The largest buyer was Polar Capital, adding an estimated $6.22M. The largest seller was First Manhattan, cutting an estimated $2.91M.

  • 39 institutional investors held BELLUS Health Inc. (BLU) as of Q4 2019, down from 40 in Q3 2019.
  • Funds reported $216M of BELLUS Health Inc. stock for Q4 2019, up 27% quarter-over-quarter.
  • 10 funds opened new BELLUS Health Inc. positions in Q4 2019 and 6 closed out, a net change of +4 holders.
  • The largest BELLUS Health Inc. buyer in Q4 2019 was Polar Capital, an estimated $6.22M added.
  • The largest BELLUS Health Inc. seller in Q4 2019 was First Manhattan, an estimated $2.91M sold.

Based on aggregated 13F filings for Q4 2019.